276 related articles for article (PubMed ID: 27760684)
1. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
[TBL] [Abstract][Full Text] [Related]
2. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
[TBL] [Abstract][Full Text] [Related]
3. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
Cholo FA; Dada S; Martin CE; Mullick S
J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
[TBL] [Abstract][Full Text] [Related]
4. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
5. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
6. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
[TBL] [Abstract][Full Text] [Related]
7. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
8. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
[TBL] [Abstract][Full Text] [Related]
9. PrEP implementation research in Africa: what is new?
Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
[TBL] [Abstract][Full Text] [Related]
10. Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States.
Taggart T; Bond KT; Ritchwood TD; Smith JC
J Int AIDS Soc; 2019 Jul; 22(7):e25363. PubMed ID: 31369211
[TBL] [Abstract][Full Text] [Related]
11. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
12. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
13. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
Gill K; Johnson L; Dietrich J; Myer L; Marcus R; Wallace M; Pidwell T; Mendel E; Fynn L; Jones K; Wiesner L; Slack C; Strode A; Spiegel H; Hosek S; Rooney J; Gray G; Bekker LG
Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803
[TBL] [Abstract][Full Text] [Related]
14. Implementing Differentiated and Integrated HIV Prevention Services for Adolescent Girls and Young Women: Experiences From Oral PrEP Rollout in Primary Care Services in South Africa.
Butler V; Kutywayo A; Martin CE; Pleaner M; Mojapele MV; Ncube S; Fipaza Z; Mundeta B; Mullick S
J Adolesc Health; 2023 Dec; 73(6S):S58-S66. PubMed ID: 37953010
[TBL] [Abstract][Full Text] [Related]
15. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
[TBL] [Abstract][Full Text] [Related]
16. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
[TBL] [Abstract][Full Text] [Related]
17. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
18. Implementation Strategies to Increase PrEP Uptake in the South.
Sullivan PS; Mena L; Elopre L; Siegler AJ
Curr HIV/AIDS Rep; 2019 Aug; 16(4):259-269. PubMed ID: 31177363
[TBL] [Abstract][Full Text] [Related]
19. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa.
Busang J; Zuma T; Herbst C; Okesola N; Chimbindi N; Dreyer J; Mtshali N; Smit T; Ngubane S; Hlongwane S; Gumede D; Jalazi A; Mdluli S; Bird K; Msane S; Danisa P; Hanekom W; Lebina L; Behuhuma N; Hendrickson C; Miot J; Seeley J; Harling G; Jarolimova J; Sherr L; Copas A; Baisley K; Shahmanesh M
BMC Public Health; 2023 Aug; 23(1):1553. PubMed ID: 37582746
[TBL] [Abstract][Full Text] [Related]
20. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
